PharmaBlock highlights green chemistry and sustainability progress in 2024 ESG report

Pharmablock Sciences (Nanjing) released its 2024 Environmental, Social, and Governance (ESG) Report, detailing its sustainability efforts and achievements. The report highlights the company's focus on green chemistry innovations, including continuous flow technology and metal catalysis, contributing to a 20% application rate of green chemistry in production projects. Environmental initiatives included a total investment of CNY 49.87 million in environmental protection, resulting in a significant reduction in energy consumption and emissions intensity. The company also reported a customer satisfaction rate of 97%. Social contributions included initiatives in employee training, community engagement, and responsible supply chain management. The report emphasizes Pharmablock's dedication to sustainable practices and alignment with the United Nations Sustainable Development Goals. Research and development investments reached CNY 107.33 million, representing 6.36% of revenue. The company obtained ISO certifications for all production sites as well.